Search

Displaying results 2401 - 2410 of 10000 in total

Drug
Hydroxyethyl cellulose
go.drugbank.com/drugs/DB11602
Approved
It is used as a key ingredient in many household cleaning products, lubricants and cosmetics due to its non-ionic and water-soluble nature. … It is often used as an ingredient in ophthalmic pharmaceutical preparations such as artificial tear solutions and adjunct agent in topical drug formulations to facilitate the delivery of drugs with hydrophobic
Categories: Compounds used in a research, industrial, or household setting
Drug
Menthyl salicylate
go.drugbank.com/drugs/DB11201
Approved
Menthyl salicylate is an ester of menthol and salicylic acid [L2808]. This product is used to treat minor aches and pains of the muscles/joints (e.g., arthritis, backache, sprains) [L2810].
Mixtures: Rx ActCategories: Anti-Inflammatory Agents, Non-Steroidal
Drug
Lopinavir
go.drugbank.com/drugs/DB01601
ApprovedInvestigational
Ritonavir is a potent inhibitor of the enzymes responsible for lopinavir metabolism, and its co-administration "boosts" lopinavir exposure and improves antiviral activity. … [A191757] Lopinavir was previously under investigation in combination with ritonavir for the treatment of COVID-19 caused by SARS-CoV-2.[L12012]
Mixtures: LOPIMUNE ® + RITONAVIR 10 MG - PELLETS EN CÁPSULAS ORALESCategories: Antivirals used in combination for the treatment of HIV infections, Antivirals for Systemic Use
Drug
Moexipril
go.drugbank.com/drugs/DB00691
ApprovedInvestigational
Moexipril is a non-sulfhydryl containing precursor of the active angiotensin-converting enzyme (ACE) inhibitor moexiprilat. It is used to treat high blood pressure (hypertension). … It works by relaxing blood vessels, causing them to widen. Lowering high blood pressure helps prevent strokes, heart attacks and kidney problems.
Mixtures: CO RENOPROTECCategories: Agents Acting on the Renin-Angiotensin System, Antihypertensive Agents Indicated for Hypertension
Drug
Plazomicin
go.drugbank.com/drugs/DB12615
Approved
On June 28th, 2018, plazomicin sulfate was approved by the FDA for use in adult patients for the treatment of complicated urinary tract infections (cUTI) including Pyelonephritis. … It was designed to evade all clinically relevant aminoglycoside-modifying enzymes, which contribute to the main resistance mechanism for aminoglycoside therapy [A33942].
Categories: Antibacterials for Systemic Use, Antiinfectives for Systemic Use
Drug
Triprolidine
go.drugbank.com/drugs/DB00427
Approved
First generation histamine H1 antagonist used in allergic rhinitis; asthma; and urticaria. It is a component of cough and cold medicines. It may cause drowsiness.
Mixtures: Cough-en RX Linctus, Poly Hist NCCategories: Antihistamines for Systemic Use
Drug
Pegulicianine
go.drugbank.com/drugs/DB18731
ApprovedInvestigational
Pegulicianine is an optical imaging agent indicated for fluorescence imaging in patients with breast cancer. … [L50537] Pegulicianine (under the brand name Lumisight) was approved for use by the FDA in April 2024.[L50537,L50547] It received Fast Track and priority review for this indication.[L50547]
Categories: Compounds used in a research, industrial, or household setting
Drug
Niclosamide
go.drugbank.com/drugs/DB06803
ApprovedInvestigationalVet approved
Niclosamide is an antihelminthic used for the treatment of tapeworm infections. … They are an even greater problem in domestic animals. Niclosamide, once marketed in the US under the brand name Niclocide, was voluntarily withdrawn from market by Bayer in 1996.[L11860]
Categories: Compounds used in a research, industrial, or household setting
Drug
Relacorilant
go.drugbank.com/drugs/DB14976
ApprovedInvestigational
[L56089] Relacorilant was approved by the US FDA on March 25, 2026, for use in combination with [paclitaxel] in patients with certain platinum-resistant cancers.[L56093,L56089] … Relacorilant is a first-in-class, selective glucocorticoid receptor antagonist.
Drug
Lumacaftor
go.drugbank.com/drugs/DB09280
ApprovedInvestigational
Approved for use by the Food and Drug Administration in July 2015 and by Health Canada in January 2016, Orkambi was the first combination product approved for the management of Cystic Fibrosis with delta-F508 … Lumacaftor is a drug used in combination with [DB08820] as the fixed dose combination product Orkambi for the management of Cystic Fibrosis (CF) in patients aged 6 years and older.